British Journal of Dermatology

Research Snippets
pp. i-i(1)

Updates from the British Society for Investigative Dermatology Annual Meeting, 16-18 April 2007, Nottingham, U.K.
pp. 913-916(4)
Authors: Birnie, A.; English, J.S.C.

Expert consensus: time for a change in the way we advise our patients to use topical corticosteroids
pp. 917-920(4)
Author: Bewley, A.

Interferon-α and viral triggers promote functional maturation of human monocyte-derived dendritic cells
pp. 921-929(9)
Authors: Farkas, A.; Tonel, G.; Nestle, F.O.

Loss of interferon-γ inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation
pp. 930-940(11)
Authors: Meissner, M.; Whiteside, T.L.; van Kuik-Romein, P.; Valesky, E.M.; van den Elsen, P.J.; Kaufmann, R.; Seliger, B.

In vivo evaluation of piperine and synthetic analogues as potential treatments for vitiligo using a sparsely pigmented mouse model
pp. 941-950(10)
Authors: Faas, L.; Venkatasamy, R.; Hider, R.C.; Young, A.R.; Soumyanath, A.

Increased matrix metalloproteinase-9 (MMP-9) activity observed in chronic wound fluid is related to the clinical severity of the ulcer
pp. 951-961(11)
Authors: Rayment, E.A.; Upton, Z.; Shooter, G.K.

Polymorphisms in the PTPN22 region are associated with psoriasis of early onset
pp. 962-968(7)
Authors: Smith, Rh.Ll.; Warren, R.B.; Eyre, S.; Ke, X.; Young, H.S.; Allen, M.; Strachan, D.; McArdle, W.; Gittins, M.P.; Barker, J.N.W.N.; Griffiths, C.E.M.; Worthington, J.

Noninvasive biophysical assessments of the efficacy of a moisturizing cosmetic cream base for patients with atopic dermatitis during different seasons
pp. 969-978(10)
Authors: Kikuchi, K.; Tagami, H.

Activated status of basophils in chronic urticaria leads to interleukin-3 hyper-responsiveness and enhancement of histamine release induced by anti-IgE stimulus
pp. 979-986(8)
Authors: Lourenço, F.D.; Azor, M.H.; Santos, J.C.; Prearo, E.; Maruta, C.W.; Rivitti, E.A.; Duarte, A.J.S.; Sato, M.N.

The methylation pattern of p16^INK4a gene promoter in psoriatic epidermis and its clinical significance
pp. 987-993(7)
Authors: Chen, M.; Chen, Z-Q.; Cui, P-G.; Yao, X.; Li, Y-M.; Li, A-S.; Gong, J-Q.; Cao, Y-H.

Multicentre intraindividual randomized trial of topical methyl aminolaevulinate-photodynamic therapy vs. cryotherapy for multiple actinic keratoses on the extremities
pp. 994-999(6)
Authors: Kaufmann, R.; Spelman, L.; Weightman, W.; Reifenberger, J.; Szeimies, R.-M.; Verhaeghe, E.; Kerrouche, N.; Sorba, V.; Villemagne, H.; Rhodes, L.E.

In vivo confocal scanning laser microscopy of common naevi with globular, homogeneous and reticular pattern in dermoscopy
pp. 1000-1007(8)
Authors: Ahlgrimm-Siess, V.; Massone, C.; Koller, S.; Fink-Puches, R.; Richtig, E.; Wolf, I.; Gerger, A.; Hofmann-Wellenhof, R.

Histopathologically dysplastic neurofibromas in neurofibromatosis 1: diagnostic criteria, prevalence and clinical significance
pp. 1008-1012(5)
Authors: Valeyrie-Allanore, L.; Ortonne, N.; Lantieri, L.; Ferkal, S.; Wechsler, J.; Bagot, M.; Wolkenstein, P.

Costs and cost-effectiveness of the nursing programme `Coping with itch' for patients with chronic pruritic skin disease
pp. 1013-1021(9)
Authors: van Os-Medendorp, H.; Guikers, C.L.H.; Eland-de Kok, P.C.M.; Ros, W.J.G.; Bruijnzeel-Koomen, C.A.F.M.; Buskens, E.

Method of assessing involved facial areas: rule of fours
pp. 1022-1028(7)
Authors: Yoon, H-S.; Choi, J-W.; Youn, J-I.

The health impact of pemphigus vulgaris and pemphigus foliaceus assessed using the Medical Outcomes Study 36-item short form health survey questionnaire
pp. 1029-1034(6)
Authors: Tabolli, S.; Mozzetta, A.; Antinone, V.; Alfani, S.; Cianchini, G.; Abeni, D.

RASA1 mutations may cause hereditary capillary malformations without arteriovenous malformations
pp. 1035-1040(6)
Authors: Hershkovitz, D.; Bercovich, D.; Sprecher, E.; Lapidot, M.

Dermoscopic patterns of naevi in fifth grade children of the Framingham school system
pp. 1041-1049(9)
Authors: Scope, A.; Marghoob, A.A.; Dusza, S.W.; Satagopan, J.M.; Agero, A.L.C.; Benvenuto-Andrade, C.; Lieb, J.A.; Weinstock, M.A.; Oliveria, S.A.; Geller, A.C.; Halpern, A.C.

Antinuclear antibodies in patients with polymorphic light eruption: a long-term follow-up study
pp. 1050-1054(5)
Authors: Tzaneva, S.; Volc-Platzer, B.; Kittler, H.; Hönigsmann, H.; Tanew, A.

Beneficial effect of resin salve in treatment of severe pressure ulcers: a prospective, randomized and controlled multicentre trial
pp. 1055-1062(8)
Authors: Sipponen, A.; Jokinen, J.J.; Sipponen, P.; Papp, A.; Sarna, S.; Lohi, J.

A retrospective randomly selected cohort study of D-penicillamine treatment in rapidly progressive diffuse cutaneous systemic sclerosis of recent onset
pp. 1063-1068(6)
Authors: Derk, C.T.; Huaman, G.; Jimenez, S.A.

Pimecrolimus 1% cream for the treatment of steroid-induced rosacea: an 8-week split-face clinical trial
pp. 1069-1076(8)
Authors: Lee, D.H.; Li, K.; Suh, D.H.

Efficacy and safety of retapamulin ointment as treatment of impetigo: randomized double-blind multicentre placebo-controlled trial
pp. 1077-1082(6)
Authors: Koning, S.; van der Wouden, J.C.; Chosidow, O.; Twynholm, M.; Singh, K.P.; Scangarella, N.; Oranje, A.P.

Pimecrolimus cream 1% in the long-term management of adult atopic dermatitis: prevention of flare progression. A randomized controlled trial
pp. 1083-1093(11)
Authors: Gollnick, H.; Kaufmann, R.; Stough, D.; Heikkila, H.; Andriano, K.; Grinienko, A.; Jimenez, P.

Topical glycopyrrolate for patients with facial hyperhidrosis
pp. 1094-1097(4)
Authors: Kim, W.O.; Kil, H.K.; Yoon, K.B.; Yoon, D.M.

Psoriasis treatment with etanercept and efalizumab: clinical strategies influencing treatment outcome
pp. 1098-1106(9)
Authors: Driessen, R.J.B.; Berends, M.A.M.; Boezeman, J.B.; van de Kerkhof, P.C.M.; de Jong, E.M.G.J.

Efalizumab: results of a 3-year continuous dosing study for the long-term control of psoriasis
pp. 1107-1116(10)
Authors: Leonardi, C.; Menter, A.; Hamilton, T.; Caro, I.; Xing, B.; Gottlieb, A.B.

Gene expression of cytokines in atopic eczema before and after ultraviolet A1 phototherapy
pp. 1117-1120(4)
Authors: Gambichler, T.; Kreuter, A.; Tomi, N.S.; Othlinghaus, N.; Altmeyer, P.; Skrygan, M.

Value of hormonal levels in patients with male androgenetic alopecia treated with finasteride: better response in patients under 26 years old
pp. 1121-1124(4)
Authors: Camacho, F.M.; García-Hernández, M.J.; Fernández-Crehuet, J.L.

Multiple aggressive squamous skin cancers in association with nonbullous congenital ichthyosiform erythroderma
pp. 1125-1128(4)
Authors: Brown, V.L.; Farrant, P.B.J.; Turner, R.J.; Price, M.L.; Burge, S.M.

Acute myeloid dendritic cell leukaemia with specific cutaneous involvement: a diagnostic challenge
pp. 1129-1133(5)
Authors: Ferran, M.; Gallardo, F.; Ferrer, A.M.; Salar, A.; Pérez-Vila, E.; Juanpere, N.; Salgado, R.; Espinet, B.; Orfao, A.; Florensa, L.; Pujol, R.M.

Psoriasis is associated with increased levels of serum leptin
pp. 1134-1135(2)
Authors: Wang, Y.; Chen, J.; Zhao, Y.; Geng, L.; Song, F.; Chen, H-D.

Poor long term outcome of severe alopecia areata in children treated with high dose pulse corticosteroid therapy
pp. 1136-1137(2)
Authors: Hubiche, T.; Léauté-Labrèze, C.; Taïeb, A.; Boralevi, F.

QuantiFERON^®-TB Gold testing for tuberculosis in psoriasis patients commencing anti-tumour necrosis factor α therapy
pp. 1137-1138(2)
Authors: Desai, N.; Raste, Y.; Cooke, N.T.; Harland, C.C.

Thrombotic thrombocytopenic purpura with the use of efalizumab for psoriasis
pp. 1138-1139(2)
Authors: Thachil, J.; Martlew, V.

Complementary and alternative medicine usage in rosacea
pp. 1139-1141(3)
Authors: McAleer, M.A.; Powell, F.C.

The relation between high-sensitivity C-reactive protein and maximum body mass index in patients with psoriasis
pp. 1141-1143(3)
Author: Ohtsuka, T.

Interstitial granulomatous drug reaction presenting as erythroderma: remission after discontinuation of enalapril maleate
pp. 1143-1145(3)
Authors: Chen, Y-C.; Hsiao, C-H.; Tsai, T-F.

Primary manifestation of a zosteriform lichen planus: isotopic response following herpes zoster sine herpete?
pp. 1145-1146(2)
Authors: Möhrenschlager, M.; Engst, R.; Hein, R.; Ring, J.

New-onset psoriasis following treatment with the interleukin-1 receptor antagonist anakinra
pp. 1146-1148(3)
Authors: González-López, M.A.; Martínez-Taboada, V.M.; González-Vela, M.C.; Fernández-Llaca, H.; Val-Bernal, J.F.

What do clinicians think of the recommendations made in the `Improving Outcomes for People with Skin Tumours including Melanoma'?
pp. 1148-1150(3)
Author: Roberts, D.L.L.

Nicorandil and ulcerations: a NAD/NADP and nicotinic acid-dependent side-effect?
pp. 1150-1151(2)
Authors: Trechot, P.; Barbaud, A.; Petitpain, N.; Claeys, A.; Schmutz, J.-L.

IgA autoantibodies against the NC16a domain of BP180 but not 120-kDa LAD-1 detected in a patient with linear IgA disease
pp. 1151-1153(3)
Authors: Ishii, N.; Ohyama, B.; Yamaguchi, Z.; Hashimoto, T.

Cutaneous graft-versus-host-like histology in childhood. Importance of clonality analysis in differential diagnosis. A case report
pp. 1153-1156(4)
Authors: D'hauw, A.; Seyger, M.M.B.; Groenen, P.J.T.A.; Weemaes, C.M.R.; Warris, A.; Blokx, W.A.M.

Novel substitution and frameshift mutations of CYLD in two Chinese families with multiple familial trichoepithelioma
pp. 1156-1158(3)
Authors: Liang, Y-H.; Sun, C-S.; Ye, X-Y.; Zhang, W.; Yang, S.; Zhang, X-J.

Efalizumab-induced hypertrichosis
pp. 1158-1159(2)
Authors: Rallis, E.; Tapinis, P.; Verros, C.D.

Evaluation of the reimbursement criteria for biological therapies for psoriasis in the Netherlands
pp. 1159-1161(3)
Authors: Wakkee, M.; Thio, H.B.; Spuls, P.I.; deJong, E.M.; Nijsten, T.

Onset of lichen planopilaris during treatment with etanercept
pp. 1161-1163(3)
Authors: Garcovich, S.; Manco, S.; Zampetti, A.; Amerio, P.; Garcovich, A.

Expression of matrix metalloproteinases 2, 9 and 11 in erythema multiforme: immunohistochemical comparison with Stevens-Johnson syndrome/toxic epidermal necrolysis
pp. 1163-1166(4)
Authors: Caproni, M.; Torchia, D.; Volpi, W.; Frezzolini, A.; Schena, D.; Marzano, A.; Quaglino, P.; DeSimone, C.; Parodi, A.; Fabbri, P.

Subcellular activation site of caspase-3 in apoptotic keratinocytes observed in lichenoid tissue reaction
pp. 1166-1168(3)
Authors: Yoneda, K.; Demitsu, T.; Matsuoka, Y.; Moriue, T.; Nakai, K.; Kusida, Y.; Haba, R.; Kubota, Y.

Repigmentation of vitiligo by transplantation of autologous melanocyte cells cultured on amniotic membrane
pp. 1168-1171(4)
Authors: Redondo, P.; delOlmo, J.; García-Guzman, M.; Guembe, L.; Prósper, F.

News and Notices
pp. 1171-1173(3)